Study topic
Vascular disorders and anticoagulation
NCLEX vascular chapter: PAD versus venous disease, DVT safety, heparin and warfarin monitoring, HIT, DOAC teaching, and hypertensive emergency priorities.
Vascular items ask you to tell arterial from venous disease, keep a clot from traveling, and match each anticoagulant to its lab, teaching line, and stop-the-drug emergency.
Arterial vs venous disease
| Feature | Arterial (PAD) | Venous |
|---|---|---|
| Pain pattern | Claudication with walking, relief with rest; rest pain when severe | Aching/heaviness, often with dependency |
| Skin / color | Pale, cool, weak/absent pulses; dependent rubor | Edema, brown hemosiderin staining, warmer |
| Position tip | Do not assume elevation helps arterial flow | Elevation and compression often help venous return as ordered |
DVT safety
Unilateral calf pain, swelling, warmth, and redness suggest DVT. Do not massage the leg. Anticipate diagnostic confirmation and anticoagulation, encourage prescribed activity limits, and watch for PE (sudden dyspnea, chest pain).
- Measure and compare calves when swelling is subtle.
- Early ambulation and prophylaxis strategies prevent clots; massage never treats one that already formed.
Anticoagulation map
| Drug | Monitor / key teaching | Danger cue |
|---|---|---|
| IV heparin | aPTT or anti-Xa per protocol | HIT: falling platelets + new thrombosis → stop heparin |
| Warfarin | INR; consistent vitamin K foods; bleeding precautions | Supratherapeutic INR → hold / vitamin K pathway as ordered |
| Apixaban (DOAC) | No warfarin-style INR routine; take on schedule | Bleeding; do not double doses after a miss without instruction |
| Enoxaparin SQ | Abdomen injection, no rubbing after; keep air bubble in prefilled syringe when designed that way | Bleeding, HIT risk awareness (heparin-class) |
HIT in one sentence
Heparin-induced thrombocytopenia is an immune reaction where platelets fall and paradoxically new clots form. Stop heparin products (including heparin flushes) and escalate for an alternate anticoagulation plan.
Safety
If platelets plummet on heparin and a new clot appears, stop heparin products and notify now. Continuing the infusion to “finish the day” is the wrong answer.
Injection and discharge teaching
- Enoxaparin: abdomen subcutaneous site, pinch skin, do not rub afterward.
- Warfarin: keep vitamin K intake consistent and keep the INR appointments.
- DOACs: no INR ritual like warfarin, but missed doses still matter. Follow the specific miss instructions.
- All anticoagulants: bleeding precautions (soft toothbrush, electric razor, report black stools, hematuria, severe headache).
Hypertensive emergency
Blood pressure in the severe range with end-organ signs (severe headache, blurred vision, new confusion, chest pain, dyspnea) is an emergency pathway: ABCs, close monitoring, and controlled BP reduction per orders. A silent high number without symptoms is urgent too, but neurologic change moves the client to the front of the line.
The nursing priority is recognizing end-organ involvement and starting the ordered urgent pathway, not offering reassurance that “numbers run high sometimes.”
Priority map
| Picture | First move |
|---|---|
| Calf pain with walking, relief at rest | PAD pattern; protect arterial perfusion teaching |
| Unilateral swollen warm calf | DVT pathway; no massage |
| Heparin + platelets 85k + new clot | Stop heparin; HIT pathway |
| Warfarin INR extremely high | Hold warfarin; anticipate vitamin K / protocol |
| BP 220/124 + confusion/vision change | Hypertensive emergency escalation |
Must know
- 1PAD: intermittent claudication (calf pain with walking that eases with rest), pale/cool extremity, weak pulses, dependent rubor pattern. Elevate-the-legs logic from venous disease does not fix arterial ischemia.
- 2Venous insufficiency: edema, brownish discoloration, aching improved with elevation/compression as ordered.
- 3Acute DVT: unilateral swelling/pain/warmth. Do not massage the limb. Anticipate anticoagulation and activity limits per order.
- 4IV heparin monitoring: aPTT (or anti-Xa per protocol). Warfarin monitoring: INR.
- 5Warfarin teaching: consistent vitamin K intake, bleeding precautions, INR follow-up. Very high INR (e.g., ~10) even without bleeding often brings vitamin K / hold pathway per order.
- 6HIT picture: falling platelets on heparin plus new thrombosis. Stop heparin (including flushes) and escalate; do not just “watch the count.”
- 7Apixaban and similar DOACs: no routine INR monitoring like warfarin; bleeding precautions still apply; do not skip doses.
- 8Enoxaparin SQ: abdomen (love-handle area), pinch skin, do not rub after injection, do not expel the air bubble in prefilled syringes designed to keep it.
- 9Hypertensive emergency: very high BP with end-organ cues (severe headache, vision change, new confusion) needs controlled urgent treatment, not casual recheck-only care.
Memory hooks
Pain with walking = arterial until proven otherwise
Claudication that stops with rest is classic PAD. Venous disease complains more about edema and aching with dependency.
Heparin short; warfarin INR
IV heparin is tracked with aPTT/anti-Xa. Warfarin is tracked with INR. Do not swap the labs.
Platelets fall + new clot on heparin = HIT
Stop heparin products and escalate. A new DVT during heparin therapy with crashing platelets is not a coincidence to ignore.
How it's tested
Stems contrast claudication with venous edema, ask which lab monitors warfarin versus heparin, or show platelets crashing with a new clot on heparin. Distractors massage a DVT, elevate arterial legs as the main cure, or keep heparin running through HIT.